These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 3931287)

  • 1. Effect of stanozolol on factors VIII and IX and serum aminotransferases in haemophilia.
    Greer IA; Greaves M; Madhok R; McLoughlin K; Porter N; Lowe GD; Preston FE; Forbes CD
    Thromb Haemost; 1985 Jun; 53(3):386-9. PubMed ID: 3931287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Danazol increases factor VIII and factor IX in classic hemophilia and Christmas disease.
    Gralnick HR; Rick ME
    N Engl J Med; 1983 Jun; 308(23):1393-5. PubMed ID: 6405274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Danazol fails to increase factor VIII or IX levels in a double-blind crossover study of patients with haemophilia A and B.
    Nugent DJ; Bray GL; Counts RB; Clements MJ; Thompson AR
    Br J Haematol; 1986 Nov; 64(3):493-502. PubMed ID: 3098273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of coagulation factor replacement with and without prednisolone in the treatment of haematuria in haemophilia and Christmas disease.
    Rizza CR; Kernoff PB; Matthews JM; McLennan CR; Rainsford SG
    Thromb Haemost; 1977 Feb; 37(1):86-90. PubMed ID: 320712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of factor VIII and IX inhibitors with ABO blood groups in 150 patients with haemophilia A and B.
    Torghabeh HM; Pourfathollah A; Shooshtari MM; Yazdi ZR
    Iran J Allergy Asthma Immunol; 2006 Mar; 5(1):33-4. PubMed ID: 17242502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of correlation between X chromosome inactivation pattern and plasma concentration of factor VIII and factor IX in carriers of haemophilia A and B.
    Orstavik KH; Scheibel E; Ingerslev J; Schwartz M
    Thromb Haemost; 2000 Mar; 83(3):433-7. PubMed ID: 10744150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Revision consensus hemophilia: treatment and responsibility. Nederlandse Vereniging van Hemophilia Patients].
    Briët E; Mauser-Bunschoten EP
    Ned Tijdschr Geneeskd; 1997 Dec; 141(52):2566-71. PubMed ID: 9555158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of coagulation equilibrium at baseline and during factor VIII and factor IX replacement in haemophiliacs.
    Négrier C; Menart C; Attali O; Petit PY; Lienhart A; Dechavanne M; Ingerslev J
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S135-41. PubMed ID: 9819045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Danazol therapy in haemophilia.
    Heaton DC; Wyld PJ; Conder JL
    N Z Med J; 1986 Mar; 99(798):185-7. PubMed ID: 3517712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prophylaxis in patients with haemophilia complicated by inhibitors].
    Paweł Ł
    Pol Merkur Lekarski; 2011 Mar; 30(177):211-4. PubMed ID: 21545000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab in the treatment of alloimmune factor VIII and IX antibodies in two children with severe haemophilia.
    Mathias M; Khair K; Hann I; Liesner R
    Br J Haematol; 2004 May; 125(3):366-8. PubMed ID: 15086418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 6-year follow-up of dosing, coagulation factor levels and bleedings in relation to joint status in the prophylactic treatment of haemophilia.
    Ahnström J; Berntorp E; Lindvall K; Björkman S
    Haemophilia; 2004 Nov; 10(6):689-97. PubMed ID: 15569163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current clinical aspects in hemophilia treatment].
    Meili EO
    Schweiz Med Wochenschr; 1989 Sep; 119(39):1332-41. PubMed ID: 2508219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unintended benefit of anabolic steroid use in hemophilia B leiden.
    Rimmer EK; Seftel MD; Israels SJ; Houston DS
    Am J Hematol; 2012 Jan; 87(1):122-3. PubMed ID: 22038733
    [No Abstract]   [Full Text] [Related]  

  • 15. Factor VIII and IX variants. Relationship between haemophilia B M and haemophilia B+.
    Meyer D; Larrieu MJ; Obert B
    Eur J Clin Invest; 1971 Sep; 1(6):425-31. PubMed ID: 5121733
    [No Abstract]   [Full Text] [Related]  

  • 16. Substitution treatment of hemophilia a and b.
    Duckert F
    Schweiz Med Wochenschr; 1975 Jun; 105(24):783-4. PubMed ID: 1145162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management.
    Mahasandana C; Patharathienskul D; Suvatte V
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():106-12. PubMed ID: 7886549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of prothromboplastin factors (Factors VIII, IX, XI and XII)].
    Kagami M
    Nihon Rinsho; 1976; 34 suppl():2407-24. PubMed ID: 792517
    [No Abstract]   [Full Text] [Related]  

  • 19. [Determination of the deficient factor in hemophilic patients].
    Peñaloza-Santillán JA; Arias y Arias J; Resano-Pérez F
    Bol Med Hosp Infant Mex; 1975; 32(1):51-9. PubMed ID: 1109289
    [No Abstract]   [Full Text] [Related]  

  • 20. [The position of a vasopressin derivative ("DDAVP") in the treatment of haemophilia A (author's transl)].
    Blättler W; Jacky E; Müller M; Graf M; Meili E
    Ther Umsch; 1979 Apr; 36(4):330-3. PubMed ID: 377557
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.